Ads
related to: merck+%26+co
Search results
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Zacks via Yahoo Finance· 3 days agoThis ETF has heaviest allocation in the Healthcare sector--about 100% of the portfolio. Looking at...
Summit Therapeutics sees stock soar 272% after lung cancer clinical trial - Silicon Valley Business...
The Business Journals· 6 days ago(Nasdaq: SMMT) — led by the team that scored success with blood cancer drug developer Pharmacyclics...
Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar?
Zacks· 6 days agoFree Report) was launched on 10/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Value segment of the US equity market. The fund is ...
Summit Therapeutics stock rallies as institutional buyer loads up on shares | Invezz
Invezz· 3 days agoSummit Therapeutics Inc (NASDAQ: SMMT) says it raised $200 million via an offer it accepted from an...
What drug manufacturer Lonza plans to do with Genentech's soon-to-be-former Vacaville site - San...
The Business Journals· 1 day agoThe deal, announced in March, remains in the process of regulatory approval, said Hyvert, who noted...
‘I can’t explain why’: Does this dog dewormer cure cancer? These Facebook groups say yes
The Daily Dot· 6 days agoThree months later, the cancer had grown. From a cattle farm in Louisiana where she’s helping a...
Summit Therapeutics' stock surges as lung-cancer treatment vies with Merck's blockbuster
Morningstar· 6 days agoShares of Summit Therapeutics Inc. (SMMT) jumped more than 270% Thursday after the company said its experimental cancer drug outperformed Merck & Co. Inc ...
A Deeper Look at Anti-PD-1/PD-L1 Checkpoint Inhibitors for Cancer
Forbes· 6 days agoIn a previous story, I described pembrolizumab, a PD-1 targeting checkpoint inhibitor, in some...
FDA delays decision on Dupixent in COPD; Summit makes a bold claim
BioPharma Dive via Yahoo Finance· 6 days agoRegeneron and Sanofi now expect an FDA verdict in September. Elsewhere, Summit claimed victory over...
Summit Shares Soar After Lung Cancer Drug Tops Keytruda in Study
Bloomberg· 6 days agoSummit Therapeutics Inc. shares jumped after the biotech company said a late-stage trial met its...